Anterior Uveitis (AU) Completed Phase 4 Trials for Certolizumab pegol (DB08904)

Also known as: Anterior uveitis / Uveitis, Anterior / Uveitis NOS / Unspecified iridocyclitis / Iridocyclitis / Uveitis anterior

IndicationStatusPhase
DBCOND0081707 (Anterior Uveitis (AU))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03020992A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AUTreatment